Bioscience leaders in New Haven Biz Power 25
Meet New Haven Biz’s 2021 Power 25. If there is anything the coronavirus pandemic has taught us, it’s the need for smart, competent and honest...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Meet New Haven Biz’s 2021 Power 25. If there is anything the coronavirus pandemic has taught us, it’s the need for smart, competent and honest...
Did you miss the BioCT Directors Series presentation, hosted by Mostafa Analoui, Ph.D., exploring the broad range of investment vehicles available to life sciences innovators? To...
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential...
The pandemic has dramatically increased demand for masks and created an environmental problem. Many people do not dispose of their masks properly, leaving them littering...
Biohaven Pharmaceuticals released preliminary fourth-quarter figures Monday showing sales of the drug, Nurtec ODT, nearly doubled compared to the previous quarter. Biohaven said the orally...
Following the already announced merger of Butterfly Network with Longview Acquisition Corp., Dr. Todd Fruchterman will become Butterfly’s president and CEO. Butterfly chairman Dr. Jonathan...
As a professor of molecular biology and biophysics in UConn’s School of Medicine, Jeff Hoch uses nuclear magnetic resonance (NMR) to study protein structure and...
New Haven biotech Kleo Pharmaceuticals is collaborating with a South Korean company to advance a potential drug targeting COVID-19. The Science Park-based startup said it...
UConn researcher Jinbo Bi is using machine learning to better understand the genetic basis for substance use disorder. One of the challenges for researchers studying...
Why are men are 1.7 times more likely to die from the COVID-19 virus than women? Yale immunobiologist Akiko Iwasaki is studying the disparate immune responses...